Literature DB >> 10692980

Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus.

J O Christensen1, O L Svendsen.   

Abstract

The aim of the study was to compare bone mineral density (BMD) and bone turnover in pre- and postmenopausal women with insulin-dependent diabetes mellitus (IDDM), non-insulin-dependent diabetes mellitus (NIDDM) and normal reference women. In a cross-sectional study 31 and 11 premenopausal and 22 and 21 postmenopausal IDDM and NIDDM patients, respectively, were recruited from an outpatient clinic. BMD in the forearm, spine, femur and total body and biochemical markers of bone turnover were measured and compared with reference values obtained from measurements of normal healthy pre- and postmenopausal women. Postmenopausally, but not premenopausally, IDDM patients had lower BMD values than NIDDM patients. Postmenopausal NIDDM patients had higher BMD value than normal women. The differences in BMD between IDDM and NIDDM patients could be explained statistically by differences in body weight between the NIDMM (obese) and IDDM (lean) women. Markers of bone turnover were significantly higher postmenopausally than premenopausally in both IDDM and NIDDM patients. Osteocalcin was significantly lower in postmenopausal NIDDM compared with postmenopausal IDDM patients and reference values. Otherwise there were no differences in the markers of bone turnover between NIDDM and IDDM patients. In conclusion, postmenopausal IDDM patients have a relatively decreased BMD, whereas NIDDM patients seem to be relatively protected from postmenopausal bone loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10692980     DOI: 10.1007/s001980050232

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  27 in total

Review 1.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

Review 3.  A critical review of diabetes, glycemic control, and dental implant therapy.

Authors:  Thomas W Oates; Guy Huynh-Ba; Adriana Vargas; Peggy Alexander; Jocelyne Feine
Journal:  Clin Oral Implants Res       Date:  2011-11-24       Impact factor: 5.977

Review 4.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

5.  Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.

Authors:  S Gul Oz; Gulay Sain Guven; Alpaslan Kilicarslan; Nursel Calik; Yavuz Beyazit; Tumay Sozen
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

Review 6.  Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers.

Authors:  J Starup-Linde; S A Eriksen; S Lykkeboe; A Handberg; P Vestergaard
Journal:  Osteoporos Int       Date:  2014-03-28       Impact factor: 4.507

7.  Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.

Authors:  I I de Liefde; M van der Klift; C E D H de Laet; P L A van Daele; A Hofman; H A P Pols
Journal:  Osteoporos Int       Date:  2005-06-07       Impact factor: 4.507

8.  Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus.

Authors:  P F Shan; X P Wu; H Zhang; X Z Cao; L Q Yuan; E Y Liao
Journal:  J Endocrinol Invest       Date:  2010-08-31       Impact factor: 4.256

9.  Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

Authors:  Zehra Berberoglu; Aynur Aktas; Yasemin Fidan; Ayse Canan Yazici; Yalcin Aral
Journal:  J Bone Miner Metab       Date:  2014-01-16       Impact factor: 2.626

10.  Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.

Authors:  D von Muhlen; S Safii; S K Jassal; J Svartberg; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.